Sumudu Narayana

729 total citations
19 papers, 553 citations indexed

About

Sumudu Narayana is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sumudu Narayana has authored 19 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Sumudu Narayana's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatitis C virus research (7 papers). Sumudu Narayana is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatitis C virus research (7 papers). Sumudu Narayana collaborates with scholars based in Australia, United States and Switzerland. Sumudu Narayana's co-authors include Karla J. Helbig, Nicholas S. Eyre, Erin M. McCartney, Michael R. Beard, Guillaume Fiches, Rowena A. Bull, Andrew R. Lloyd, Auda A. Eltahla, Rohit K. Jangra and Kui Li and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Sumudu Narayana

15 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumudu Narayana Australia 7 249 171 146 137 134 19 553
Nan L. Li United States 8 301 1.2× 186 1.1× 127 0.9× 157 1.1× 123 0.9× 9 542
Katharina Esser‐Nobis Germany 12 342 1.4× 334 2.0× 298 2.0× 258 1.9× 228 1.7× 17 862
Mohit Sehgal United States 11 325 1.3× 142 0.8× 232 1.6× 241 1.8× 116 0.9× 15 630
Robert A. LeDesma United States 5 192 0.8× 106 0.6× 116 0.8× 173 1.3× 81 0.6× 6 449
Karel A. van Dort Netherlands 15 288 1.2× 262 1.5× 216 1.5× 106 0.8× 187 1.4× 31 719
Lina Mouna France 9 85 0.3× 333 1.9× 92 0.6× 117 0.9× 86 0.6× 24 513
Glòria Martrus Germany 15 510 2.0× 94 0.5× 111 0.8× 83 0.6× 47 0.4× 26 696
Amanda Goodsell United States 11 315 1.3× 289 1.7× 104 0.7× 102 0.7× 125 0.9× 19 688
Philipp Schult Germany 9 78 0.3× 147 0.9× 197 1.3× 71 0.5× 133 1.0× 13 457
Moeko Miyashita Japan 6 658 2.6× 129 0.8× 404 2.8× 143 1.0× 52 0.4× 6 818

Countries citing papers authored by Sumudu Narayana

Since Specialization
Citations

This map shows the geographic impact of Sumudu Narayana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumudu Narayana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumudu Narayana more than expected).

Fields of papers citing papers by Sumudu Narayana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumudu Narayana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumudu Narayana. The network helps show where Sumudu Narayana may publish in the future.

Co-authorship network of co-authors of Sumudu Narayana

This figure shows the co-authorship network connecting the top 25 collaborators of Sumudu Narayana. A scholar is included among the top collaborators of Sumudu Narayana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumudu Narayana. Sumudu Narayana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ramachandran, Jeyamani, et al.. (2025). A qualitative enquiry into participants’ and practitioners’ experiences in the Australian Liver FaIlurE trial. PubMed Central. 15(2). e089666–e089666.
2.
3.
Wigg, Alan, Sumudu Narayana, Richard Woodman, et al.. (2024). A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The Australian Liver Failure (ALFIE) trial. Hepatology. 81(1). 136–151. 2 indexed citations
4.
Bidargaddi, Niranjan, et al.. (2023). Integrating smart phone applications in the management of cirrhotic patients: A scoping review. JGH Open. 7(12). 826–831. 1 indexed citations
5.
Woodman, Richard, et al.. (2022). Association of physiological reserve measures with adverse outcomes following liver transplantation. JGH Open. 6(2). 132–138. 2 indexed citations
6.
Woodman, Richard, Kate Muller, Mohamed Asif Chinnaratha, et al.. (2022). High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: An Australian multicenter study. JGH Open. 6(9). 599–606. 3 indexed citations
7.
Wigg, Alan, Sumudu Narayana, Günter Härtel, et al.. (2021). Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine. 36. 100919–100919. 19 indexed citations
8.
Ramachandran, Jeyamani, et al.. (2021). Outcomes of transjugular intrahepatic portosystemic shunt procedures: a 10‐year experience. Journal of Medical Imaging and Radiation Oncology. 65(6). 655–662. 6 indexed citations
9.
Narayana, Sumudu, Michael Nugent, Richard Woodman, et al.. (2021). Measuring quality of hepatitis B care in a remote Australian Aboriginal community: opportunities for improvement. Internal Medicine Journal. 52(8). 1347–1353. 2 indexed citations
10.
Wundke, Rachel, Rosemary McCormick, Sumudu Narayana, Lea Sorensen, & Alan Wigg. (2020). The Chronic Liver Disease Nurse Role in Australia. Gastroenterology Nursing. 43(1). E9–E15. 6 indexed citations
11.
Wigg, Alan, Sumudu Narayana, Jeyamani Ramachandran, et al.. (2019). High rates of indeterminate interferon‐gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates. Transplant Infectious Disease. 21(3). e13087–e13087. 11 indexed citations
12.
McCartney, Erin M., et al.. (2019). Clinical factors leading to a change in management in chronic hepatitis B patients managed in a tertiary setting. Internal Medicine Journal. 50(2). 177–184.
13.
Wigg, Alan, Sumudu Narayana, Hien Le, et al.. (2019). Stereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience. ANZ Journal of Surgery. 89(9). 1138–1143. 5 indexed citations
14.
Wigg, Alan, Rachel Wundke, Rosemary McCormick, et al.. (2018). Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 17(6). 1210–1212.e1. 11 indexed citations
15.
Narayana, Sumudu, Karla J. Helbig, Erin M. McCartney, et al.. (2015). The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry. Journal of Biological Chemistry. 290(43). 25946–25959. 136 indexed citations
16.
Aloia, Amanda L., Nicholas S. Eyre, Stuart Black, et al.. (2014). Generation of a Chimeric Hepatitis C Replicon Encoding a Genotype-6a NS3 Protease and Assessment of Boceprevir (SCH503034) Sensitivity and Drug-Associated Mutations. Antiviral Therapy. 20(3). 271–280. 4 indexed citations
17.
Helbig, Karla J., Jillian M. Carr, Jennifer N. Clarke, et al.. (2013). Viperin Is Induced following Dengue Virus Type-2 (DENV-2) Infection and Has Anti-viral Actions Requiring the C-terminal End of Viperin. PLoS neglected tropical diseases. 7(4). e2178–e2178. 131 indexed citations
18.
McCartney, Erin M., Karla J. Helbig, Sumudu Narayana, et al.. (2013). Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology. 58(5). 1558–1568. 54 indexed citations
19.
Helbig, Karla J., Nicholas S. Eyre, Sumudu Narayana, et al.. (2011). The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology. 54(5). 1506–1517. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan L. Li Breakdown of academic impact, for papers by Katharina Esser‐Nobis Breakdown of academic impact, for papers by Mohit Sehgal Breakdown of academic impact, for papers by Robert A. LeDesma Breakdown of academic impact, for papers by Karel A. van Dort Breakdown of academic impact, for papers by Lina Mouna Breakdown of academic impact, for papers by Glòria Martrus Breakdown of academic impact, for papers by Amanda Goodsell Breakdown of academic impact, for papers by Philipp Schult Breakdown of academic impact, for papers by Moeko Miyashita
Rankless by CCL
2026